Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Prudential PLC (PUK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Prudential PLC — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B), while Prudential PLC trades at $23.79 (market cap $29.25B). The key difference: Prudential PLC is far larger — about 3.5× Hinge Health Inc. Class A Common Stock's market cap, and Prudential PLC pays a 2.33% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Prudential PLC for 119 Days on average.
| HNGE | PUK | |
|---|---|---|
Market Cap | $8.47B | $29.25B |
Volume | 1,624,526 | 1,214,779 |
Sector | Health | Financials |
52-Week High | $105.14 | $33.61 |
52-Week Low | $31.17 | $23.54 |
Typical Hold Time | 0 Days | 119 Days |
Enterprise Value | $8.09B | $28.79B |
Dividend Yield | — | 2.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Prudential (PUK) trades at $23.83, down 0.17% with a bearish technical signal. The company shows strong fundamentals with 2025 revenue of $27.39B and net income of $3.98B, supported by a 14.52% profit margin and attractive valuation ratios including a P/E of 8.38. Recent strategic moves include exiting emerging markets and focusing on core operations, with analyst consensus leaning positive despite mixed quarterly earnings performance.
The outlook remains cautiously optimistic given solid profitability and strategic repositioning, though risks include execution of the $3B capital rotation plan and market volatility. With 50% of analysts rating it Buy and technical indicators showing oversold conditions, the stock presents value potential for patient investors despite near-term bearish momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Prudential PLC
Prudential is an Asia and Africa health and life insurance business and is focused on long-term savings. The business is increasingly focusing on digital offerings and creating strong brand equity and relationships with customers of its products through these.
Read more on PUK →
